ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 673131 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 673131; 2) Community: the network communities that were significantly associated with the response to NSC 673131; 3) Molecule: the relationships between components within communities and NSC 673131; 4) MDR: the compounds that were significantly associated with the NSC 673131.

NSC Compound Enrichment Correlation
NSC 633942 Null 0.000775017394067549 0.18481845
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.00304217761766477 0.15643434
NSC 752270 2,7-Bis-[3-(2-chloro-benzylamino)-propyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate 0.00304217761766482 -0.20324177
NSC 729797 5-({[4-(1,3-benzoxazol-2-yl)phenyl]amino}methylene)pyrimidin e-2,4,6(1H,3H,5H)-trione 0.00382947473644656 -0.30190424
NSC 175630 Toyocamycin, 6-amino- 0.00456325077253396 -0.022077213
NSC 338947 Clomesone 0.00456325077253396 0.36356331
NSC 642293 Null 0.00456325077253396 0.2453116
NSC 652562 Null 0.00456325077253396 0.17527116
NSC 667047 2-propenyl estradiol 0.00456325077253396 0.18313656
NSC 689137 Null 0.00456325077253399 0.32047901
Total:20  Current:1    [First] [Prev] [Next] [Last]